Appendix A: List of tests and references
H: Cannabis abuse screening test (CAST) (Beck and Legleye, 2003)
I: ALAC (ALAC, 1996)
1 Have people close to you complained about your cannabis use? 1 Yes 2 No 2 Do you have problems with short-term memory? 1 Yes 2 No 3 Have you experienced ‘paranoid’ episodes following cannabis use? 1 Yes 2 No 4 Do you consider it difficult to go through a day without a ‘joint’? 1 Yes 2 No 5 Do you lack the energy to get things done in the way you used to? 1 Yes 2 No 6 Do you ever worry about the effects of your cannabis use? 1 Yes 2 No 7 Do you have more difficulty in understanding new information?
(difficulty in studying) 1 Yes 2 No
8 Have you ever unsuccessfully attempted to cut down or stop your cannabis use?
1 Yes 2 No 9 Do you like to get ‘stoned’ in the morning? 1 Yes 2 No 10 Are you spending more and more time ‘stoned’? 1 Yes 2 No 11 Do you experience cravings, headaches, irritability or difficulty in
concentration when you cut down or cease cannabis use?
1 Yes 2 No
Measuring cannabis-related problems and dependence at the population level
54
Bibliography
Aarons, G., Brown, S., Stice, E., Coe, M. (2001), ‘Psychometric evaluation of the marijuana and stimulant effect expectancy questionnaires for adolescents’, Psychology of Addictive Behaviors 26(2): 219–236.
Adamson, S. J., Sellman, J. D. (2003), ‘A prototype screening instrument for cannabis use disorder:
the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample’, Drug and Alcohol Review 22: 309–315.
ALAC (1996), Guidelines for alcohol and drug assessment: a review of alcohol and drug screening, diagnostic and evaluation instruments, Alcohol Advisory Council of New Zealand, Wellington.
APA (1994), Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV), American Psychiatric Association, Washington DC.
Bailly, D. (1997), ‘From drug use to drug abuse: a developmental perspective’ in Scientific meeting of the European Chapter of International Association for Adolescent Health, Lausanne.
Bailly, D. (1998), ‘Inscription du sevrage dans le long terme’, in Troisième conférence de consensus sur les ‘modalités de secrage chez les toxicomanes dépendant des opiacés’, Paris.
Beck, F., Legleye, S. (2003), Drogues et adolescence. Usages de drogues et contextes d’usage entre 17 et 19 ans, évolutions récentes, ESCAPAD (2002), Rapport OFDT.
Beck, F., Legleye, S. (2007a), Screening problematic cannabis use in epidemiological research and in general population: tools, validation and references, OFDT working paper.
Beck, F., Legleye, S. (2007b), ‘Le repérage des consommations problématiques’, in Costes et al.
(eds), Cannabis: données éssentielles, OFDT, Paris.
Beck, F., Legleye, S., Spilka, S. (2004), Drogues à l’adolescence. Niveaux et contextes d’usage de substances psychoactives à 17–18 ans en France, ESCAPAD (2003), Rapport OFDT www.ofdt.fr/BDD/publications/fr/escap03.htm
Bisson, J., Nadeau, L., Demers, A. (1999), ‘The validity of the CAGE scale to screen for heavy drinking and drinking problems in a general population survey’, Addiction 94(5): 715–722.
Bless, R., Korf, D., Riper, H., Diemel, S. (1997), Improving the comparability of general population surveys on drug use in the European Union, Final report, commissioned by EMCDDA.
Bukstein, O., Kaminer, Y. (1994), ‘The nosology of adolescent substance abuse’ American Journal on Addictions 3: 1–13.
Chabrol, H., Fredaigue, N., Callahan, S. (2000), ‘Epidemiological study of cannabis abuse and dependence in 256 adolescents’, Encephale 26(4): 47–49.
Coffey, C., Carlin, J., Degenhardt, L., Lynskey, M., Sanci, L., Patton, G. (2002), ‘Cannabis dependence in young adults: an Australian population study’, Addiction 97: 187–194.
Compton, D. R., Dewey, W. L., Martin, B. R. (1990), ‘Cannabis dependence and tolerance production’, Advances in Alcohol and Substance Abuse 9(1–2): 129–147.
Compton, W. M., Cottler, L. B., Dorsey, K. B., Spitznagel, L., Mager, D. E. (1996), ‘Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN’, Drug and Alcohol Dependence 41: 179–187.
Copeland, J., Gilmour, S., Gates, P., Swift, W. (2005), ‘The Cannabis Problems Questionnaire: factor structure, reliability and validity’, Drug and Alcohol Dependence 80(3): 313–319.
Crowley, T. J., Macdonald, M. J., Whitmore, E. A., Mikulich, S. K. (1998), ‘Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders’, Drug and Alcohol Dependence 50: 27–37.
Daeppen, J.-B. (dir.) (2004), ‘Interventions brève en alcoologie’, Alcoologie et addictologie 26(3 suppl.): 3S–40S.
Dale, A. (2003), ‘A marijuana screening inventory (experimental version): description and preliminary psychometric properties’, American Journal of Drug and Alcohol Abuse 29(3): 619–646.
Chapter 2
55 Dennis, M., Titus, J., Diamond, G., Donaldson, J., Godley, S., Tims, F., Webb, C., Kaminer, Y.,
Babor, T., Roebuck, M., Godley, M., Hamilton, N., Liddle, H., Scott, C., The C. Y. T. Steering Committee (2002), ‘The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans’, Addiction 97(s1): 16–34.
Edwards, G., Arif, A., Hodgson, R. (1981), ‘Nomenclature and classification of drug and alcohol related problems’, Bulletin of World Health Organisation 59: 225–242.
EMCDDA (2002), Annual report on the state of the drugs problem in the European Union and Norway, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
EMCDDA (2007), Annual report on the state of the drugs problem in the European Union and Norway, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
Ewing, J. A. (1984), ‘Detecting alcoholism: the CAGE questionnaire’, Journal of the American Medical Association 252: 1905–1907.
Fagerström, K. O., Schneider, N. G. (1989), ‘Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire’, Journal of Behavioral Medicine 12: 159–182.
Ferris, J., Templeton, L., Wong, S. (1994), Alcohol, tobacco and marijuana: use, norms, problems and policy attitudes among Ontario adults, Addiction Research Foundation, Toronto, ARF internal document.
Galen, L. W., Henderson, M. J. (1999), ‘Validation of cocaine and marijuana effect expectancies in a treatment setting’, Addictive Behaviors 24(5): 719–724.
Goodman, A. (1990), ‘Addiction: definition and implication’, British Journal of Addictions 85:
1403–1408.
Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W. (1995), ‘The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users’, Addiction 90: 607–614.
Hall, W., Solowij, N., Lemon, J. (1994), The health and psychological consequences of cannabis use, Australian Government Publishing Service, Canberra, pp. 136–139.
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., Fischman, M. W. (1999a), ‘Abstinence symptoms following oral THC administration to humans’, Psychopharmacology 141(4): 385–394.
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., Fischman, M. W. (1999b), ‘Abstinence symptoms following smoked marijuana in humans’, Psychopharmacology 141(4): 395–404.
Harrison, P.-A., Fulkerson, J.-A., Beebe, T.-J. (1998), ‘DSM-IV substance use disorder criteria for adolescents: a critical examination based on a statewide school survey’, American Journal of Psychology 155: 486–492.
Heishman, S. J., Singleton, E. G., Liguori, A. (2001), ‘Marijuana craving questionnaire: development and initial validation of a self-report instrument’, Addiction 96(7): 1023–1034.
Hollister, L. (1986), ‘Health aspects of cannabis’, Pharmacological Reviews 38(1): 1–20.
Inserm (2001), Cannabis: quel effets sur le comportement et la santé? Synthèse et recommandations, Institut national de la santé et de la recherche médicale, Paris.
Jones, R. T. (1996), ‘Cannabis withdrawal syndrome: laboratory artifact or clinically important?’
European Neuropsychopharmacology 6(Suppl. 3): 2–2(1).
Kaminer, Y. (1994), Adolescent substance abuse. A comprehensive guide to theory and practice, Plenum Medical Book Company, New York.
Kandel, D., Chen, K., Warner, L. A., Kessler, R. C., Grant, B. (1997), ‘Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population’, Drug and Alcohol Dependence 44: 11–29.
Karila, L., Legleye, S., Beck, F., Donnadieu, S., Corruble, E., Reynaud, M. (2004), ‘Consommations nocives de produits psychoactifs: résultats préliminaires de l’étude ADOTECNO’, Alcoologie et addictologie 26(2): 99–109.
Kerssemakers, R. (2000), The Know cannabis test www.knowcannabis.org.uk/
Measuring cannabis-related problems and dependence at the population level
56
Knight, J. R., Sherritt, L., Harris, S. K., Gates E., Chang, G. (2003), ‘Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE and CRAFFT’, Alcohol Clinical and Experimental Research 27(1): 67–73.
Kraus, L., Augustin, R., Orth, B. (2005), Illegale Drogen, Einstiegsalter und Trends. Ergebnisse des Epidemiologischen Suchtsurvey 2003 (Illicit drug use, age of onset and trends. Results of the 2003 Epidemiological Survey on Substance Abuse), Sucht 51 (Sonderheft 1): S19–S28.
Langenbucher, J. W., Morgenstern, J., Miller, K. J. (1995), ‘DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence’, Drug and Alcohol Dependence 39: 139–150.
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K., Janavs, J., Dunbar, G.
(1997), ‘The MINI International neuropsychiatric interview (MINI): a short diagnostic structured interview: reliability and validity according to the CIDI’, European Psychiatry 12: 224–231.
Legleye, S., Karila, L., Beck, F., Reynaud, M. (2007), ‘Validation of the CAST, a general population Cannabis Abuse Screening Test’, The Journal of Substance Use 12(4): 233–242.
Lynskey, M., Hall, W. (2000), ‘The effects of adolescent cannabis use on educational attainment, A review’, Addiction 95(11): 1621–1630.
Martin, G., Copeland, W., Swift, W. (2005), ‘The adolescent cannabis check-up: feasibility of a brief intervention for young cannabis users’, Journal of Substance Abuse Treatment 29(3): 207–213.
Martin, G., Copeland, J., Gilmour, S., Gates, P., Swift, W. (2006), ‘The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties’, Addictive Behaviors 31(12): 2238–2248.
Midanik, L. T., Zahnd, E. G., Klein, D. (1998), ‘Alcohol and drug CAGE screeners for pregnant, low-income women: the California Perinatal Needs assessment’, Alcoholism: Clinical and Experimental Research 22(1): 121–125.
Mikulich, S. K., Hal, S. K., Whitmore, E. A., Crowley, T. J. (2001), ‘Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents’, Drug and Alcohol Dependence 61: 237–248.
Montanari, L. (2004), Clients demanding treatment for cannabis use in Europe in 2002: profile and recent trends, paper presented at KBS 2004, Helsinki.
Nurnberger, J. I. Jr., Blehar, M. C., Kaufmann, C. A., York-Cooler, C., Simpson S. G., Harkavy-Friedman, J., Severe, J., Malaspina, D., Reicht, T. (1994), ‘Diagnostic interview for genetic studies. Rationale, unique features, and training’, NIMH Genetics Initiative, Arch Gen Psychiatry 51: 849–859.
Obradovic, I. (2006), ‘Premier bilan des “consultations cannabis” ’, Tendances 50 (September 2006), OFDT, Paris.
Okulicz-Kozaryn, K., Sieroslawski, J. (2005), Screen for problematic cannabis and other drug use among adolescents — study of the test’s validity, paper presented at KBS 2005, Riverside, California.
Ramström, J. (2003), Adverse health consequences of cannabis use, National Institute of Public Health, Stockholm.
Rhem, J., Room, R., Van den Brink, W., Kraus, L. (2005), ‘Problematic drug use disorders in EU countries and Norway: an overview of the epidemiology’, European Neuropsychopharmacology 15(4): 389–397.
Rost, K., Burnam, M. A., Smith, G. R. (1993), ‘Development of screeners for depressive disorders and substance disorder history’, Medical Care 31: 189–200.
SAMHSA (2002), Summary of findings from the 2001 National Household Survey on Drug Abuse.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., Grant, M. (1993), ‘Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II’, Addiction 88(6): 791–804.
Chapter 2
57 Schafer, J., Brown, S. A. (1991), ‘Marijuana and cocaine effect expectancies and drug use patterns’,
Journal of Consulting and Clinical Psychology 59: 558–565.
Sheehan, D. V., Lecrubier, Y., Harnett-Sheehan, K., Janavs, J., Weiller, E., Bonora, L., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., Dunbar, G. (1997), ‘Reliability and validity of the MINI International Neuropsychiatric Interview (MINI): according to the SCID-P’, European Psychiatry 12: 232–241.
Simon, R. (2004), Regular and intensive use of cannabis and related problems: conceptual framework and data analysis in the EU member states, Final report to EMCDDA, CT.2003.103.P1.
Simon, R., Kraus, L. (2007), ‘Has treatment demand for cannabis-related disorders increased in Germany?’, this monograph.
Singleton, E. G., Trotman, A. J., Zavahir, M., Taylor, R. C., Heishman, S. J. (2002), ‘Determinants of the reliability and validity of the marijuana craving questionnaire using imagery scripts’, Exp Clin Psychopharmacol 10(1): 47–53.
Smith, N. (2002), ‘A review of the published literature into cannabis withdrawal symptoms in human users’, Addiction 97(6): 621–632.
Soellner, R. (2002), ‘Dependence on cannabis — an everlasting issue’ Substance Use and Misuse 40: 857–867.
Svanum, S., McGrew, J. (1995), ‘Prospective screening of substance dependence: the advantages of directness’, Addictive Behavior 20: 205–213.
Swift, W., Hall, W., Didcott, P., Reilly, D. (1998), ‘Patterns and correlates of cannabis dependence among long-term users in an Australian rural area’, Addiction 93(8): 1149–1160.
Swift, W., Hall, W., Teesson, M. (2001), ‘Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing’, Drug and Alcohol Dependence 63(2): 147–153.
Tiffany, S. T., Drobes, J. D. (1991), ‘The development and initial validation of a questionnaire on smoking urges’, British Journal of Addiction 86: 1467–1476.
Tiffany, S. T., Singleton, E., Haertzen, C. A., Henningfield, I. E. (1993), ‘The development of a cocaine craving questionnaire’, Drug and Alcohol Dependence 34: 19–28.
Vandrey, R., Budney, A. J., Kamon, J. L., Stanger, C. (2005), ‘Cannabis withdrawal in adolescent treatment seekers’, Drug and Alcohol Dependence 78: 205–210.
WHO Expert Committee on Addiction-Producing Drugs (1964), 13th Report. Geneva: WHO, Technical Report Series, No. 273.
Williams, L., Parker, H. (2001), ‘Alcohol, cannabis, ecstasy and cocaine: drug of reasoned choice amongst young adult recreational drug users in England’ International Journal of Drug Policy 12:
397–413.
Williams, B. T. R., Drummond, D. C. (1994), ‘The Alcohol Problems Questionnaire: reliability and validity’, Drug and Alcohol Dependence 35: 239–243.
59